Article info

Download PDFPDF

Original research
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Authors

  1. Correspondence to Dr Jeffrey Weber; Jeffrey.Weber{at}nyulangone.org
View Full Text

Citation

Laino AS, Woods D, Vassallo M, et al
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Publication history

  • Accepted May 20, 2020
  • First published June 23, 2020.
Online issue publication 
June 23, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.